Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-16

FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Voquezna Dual Pak (vonoprazan fumarate and amoxicillin) from Phathom Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOQUEZNA DUAL PAK (Vonoprazan fumarate and amoxicillin)

Snippet

SUPPL AP for VOQUEZNA DUAL PAK (VONOPRAZAN FUMARATE AND AMOXICILLIN)